Triple therapy halves exacerbations in moderate-to-severe COPD

Full story: Science Blog

Patients with moderate to severe chronic obstructive pulmonary disease can benefit from triple therapy that includes a long-acting I2-agonist , an inhaled corticosteroid and an anti-muscarinic agent, according to researchers in Germany.

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Foradil, Formoterol Discussions

Topic	Updated	Last By	Comments
New Warnings for 3 Asthma Drugs (Aug '06)	Nov 10	Don	23
Warnings over asthma meds (Jun '06)	Jun '09	Linda ...	44
A Single Inhaler for Your Asthma (May '09)	May '09	Nikki	1
Novartis' investigational COPD treatment may im... (May '09)	May '09	starman1695	1
FDA Panel to Scrutinize Safety of Some Asthma T... (Dec '08)	May '09	SNSB	17
FDA: Risks of new asthma drugs Advair and Serev... (Dec '08)	Jan '09	Jack50	4
Foradil for COPD (Dec '08)	Dec '08	Linda	2